RT Journal Article
SR Electronic
T1 Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.30.21254591
DO 10.1101/2021.03.30.21254591
A1 Svetoslav Nanev Slavov
A1 José Salvatore Leister Patané
A1 Rafael dos Santos Bezerra
A1 Marta Giovanetti
A1 Vagner Fonseca
A1 Antonio Jorge Martins
A1 Vincent Louis Viala
A1 Evandra Strazza Rodrigues
A1 Elaine Vieira dos Santos
A1 Claudia Renata dos Santos Barros
A1 Elaine Cristina Marqueze
A1 Bibiana Santos
A1 Flavia Aburjaile
A1 Raul Machado Neto
A1 Debora Botequio Moretti
A1 Ricardo Haddad
A1 Rodrigo Tocantins Calado
A1 João Paulo Kitajima
A1 Erika Freitas
A1 David Schlesinger
A1 Luiz Carlos Junior de Alcantara
A1 Maria Carolina Elias
A1 Sandra Coccuzzo Sampaio
A1 Simone Kashima
A1 Dimas Tadeu Covas
YR 2021
UL http://medrxiv.org/content/early/2021/04/04/2021.03.30.21254591.abstract
AB Sao Paulo State, the most populous area in Brazil, currently experiences a second wave of the COVID-19 pandemic which overwhelmed the healthcare system. Recently, due to the paucity of SARS-CoV-2 complete genome sequences, we established a Network for Pandemic Alert of Emerging SARS-CoV-2 Variants to rapidly understand the spread of SARS-CoV-2 and monitor in nearly real-time the circulating SARS-CoV-2 variants into the state. Through full genome analysis of 217 SARS-CoV-2 complete genome sequences obtained from the largest regional health departments we were able to identify the co-circulation of multiple SARS-CoV-2 lineages such as i) B.1.1 (0.92%), ii) B.1.1.1 (0.46%), iii) B.1.1.28 (25.34%), iv) B.1.1.7 (5.99%), v) B.1.566 (1.84%), vi) P.1 (64.05%), and P.2 (0.92%). Further our analysis allowed the detection, for the first time in Brazil of the South African variant of concern (VOC), the B.1.351 (501Y.V2) (0.46%). The identified lineage was characterized by the presence of the following mutations: ORF1ab: T265I, R724K, S1612L, K1655N, K3353R, SGF 3675_F3677del, P4715L, E5585D; Spike: D80A, D215G, L242_L244del, A262D, K417N, E484K, N501Y, D614G, A701V, C1247F; ORF3a: Q57H, S171L, E: P71L; ORF7b: Y10F, N: T205I; ORF14: L52F. Origin of the most recent common ancestor of this genomic variant was inferred to be between middle October to late December 2020. Analysis of generated sequences demonstrated the predominance of the P.1 lineage and allowed the early detection of the South African strain for the first time in Brazil. Our findings highlight the importance to increase active monitoring to ensure the rapid detection of new SARS-CoV-2 variants with a potential impact in pandemic control and vaccination strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Butantan Institute, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant Number. 2020/10127; 2020/05367-3), Hemocentro Ribeirao Preto.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is approved by the Institutional Ethics Committe of the Faculty of Medicine of Ribeirao Preto, University of Sao PauloAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe obtained data is being deposited in the GISAID database together with this submission.